rs45483293

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000196.4(HSD11B2):​c.534G>A​(p.Glu178Glu) variant causes a synonymous change. The variant allele was found at a frequency of 0.0367 in 1,614,214 control chromosomes in the GnomAD database, including 1,272 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 76 hom., cov: 32)
Exomes 𝑓: 0.037 ( 1196 hom. )

Consequence

HSD11B2
NM_000196.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 4.44

Publications

29 publications found
Variant links:
Genes affected
HSD11B2 (HGNC:5209): (hydroxysteroid 11-beta dehydrogenase 2) There are at least two isozymes of the corticosteroid 11-beta-dehydrogenase, a microsomal enzyme complex responsible for the interconversion of cortisol and cortisone. The type I isozyme has both 11-beta-dehydrogenase (cortisol to cortisone) and 11-oxoreductase (cortisone to cortisol) activities. The type II isozyme, encoded by this gene, has only 11-beta-dehydrogenase activity. In aldosterone-selective epithelial tissues such as the kidney, the type II isozyme catalyzes the glucocorticoid cortisol to the inactive metabolite cortisone, thus preventing illicit activation of the mineralocorticoid receptor. In tissues that do not express the mineralocorticoid receptor, such as the placenta and testis, it protects cells from the growth-inhibiting and/or pro-apoptotic effects of cortisol, particularly during embryonic development. Mutations in this gene cause the syndrome of apparent mineralocorticoid excess and hypertension. [provided by RefSeq, Feb 2010]
HSD11B2 Gene-Disease associations (from GenCC):
  • apparent mineralocorticoid excess
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 16-67436012-G-A is Benign according to our data. Variant chr16-67436012-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 586029.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0868 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HSD11B2NM_000196.4 linkc.534G>A p.Glu178Glu synonymous_variant Exon 3 of 5 ENST00000326152.6 NP_000187.3 P80365
HSD11B2XM_047434048.1 linkc.222G>A p.Glu74Glu synonymous_variant Exon 4 of 6 XP_047290004.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HSD11B2ENST00000326152.6 linkc.534G>A p.Glu178Glu synonymous_variant Exon 3 of 5 1 NM_000196.4 ENSP00000316786.5 P80365
HSD11B2ENST00000566606.1 linkn.*335G>A non_coding_transcript_exon_variant Exon 3 of 3 5 ENSP00000473429.1 R4GN04
HSD11B2ENST00000567684.2 linkn.397G>A non_coding_transcript_exon_variant Exon 3 of 4 3
HSD11B2ENST00000566606.1 linkn.*335G>A 3_prime_UTR_variant Exon 3 of 3 5 ENSP00000473429.1 R4GN04

Frequencies

GnomAD3 genomes
AF:
0.0286
AC:
4352
AN:
152224
Hom.:
76
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00871
Gnomad AMI
AF:
0.0592
Gnomad AMR
AF:
0.0290
Gnomad ASJ
AF:
0.0571
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.00931
Gnomad FIN
AF:
0.0358
Gnomad MID
AF:
0.142
Gnomad NFE
AF:
0.0401
Gnomad OTH
AF:
0.0435
GnomAD2 exomes
AF:
0.0308
AC:
7749
AN:
251448
AF XY:
0.0316
show subpopulations
Gnomad AFR exome
AF:
0.00812
Gnomad AMR exome
AF:
0.0229
Gnomad ASJ exome
AF:
0.0601
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0362
Gnomad NFE exome
AF:
0.0426
Gnomad OTH exome
AF:
0.0406
GnomAD4 exome
AF:
0.0375
AC:
54814
AN:
1461872
Hom.:
1196
Cov.:
35
AF XY:
0.0369
AC XY:
26831
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.00914
AC:
306
AN:
33480
American (AMR)
AF:
0.0233
AC:
1041
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0618
AC:
1615
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.0115
AC:
990
AN:
86258
European-Finnish (FIN)
AF:
0.0406
AC:
2166
AN:
53410
Middle Eastern (MID)
AF:
0.0933
AC:
538
AN:
5768
European-Non Finnish (NFE)
AF:
0.0411
AC:
45739
AN:
1112000
Other (OTH)
AF:
0.0400
AC:
2417
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
3686
7372
11059
14745
18431
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1704
3408
5112
6816
8520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0285
AC:
4348
AN:
152342
Hom.:
76
Cov.:
32
AF XY:
0.0274
AC XY:
2043
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00871
AC:
362
AN:
41584
American (AMR)
AF:
0.0290
AC:
444
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.0571
AC:
198
AN:
3470
East Asian (EAS)
AF:
0.000580
AC:
3
AN:
5176
South Asian (SAS)
AF:
0.00932
AC:
45
AN:
4828
European-Finnish (FIN)
AF:
0.0358
AC:
381
AN:
10628
Middle Eastern (MID)
AF:
0.133
AC:
39
AN:
294
European-Non Finnish (NFE)
AF:
0.0401
AC:
2731
AN:
68022
Other (OTH)
AF:
0.0430
AC:
91
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
221
443
664
886
1107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0375
Hom.:
63
Bravo
AF:
0.0271
Asia WGS
AF:
0.00722
AC:
25
AN:
3478
EpiCase
AF:
0.0423
EpiControl
AF:
0.0461

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 30, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 31, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apparent mineralocorticoid excess Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
7.2
DANN
Benign
0.79
PhyloP100
4.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45483293; hg19: chr16-67469915; COSMIC: COSV52097990; COSMIC: COSV52097990; API